Empowering Patients' Lung Cancer Screening Uptake

NAActive, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 13, 2023

Primary Completion Date

March 21, 2025

Study Completion Date

December 31, 2025

Conditions
Lung Cancer
Interventions
BEHAVIORAL

Patient education

Patients will be sent information (in preferred language) on lung cancer risk, lung cancer screening (LCS) benefits, harms, false positive rates, recommendations of follow-up for positive results, and exam insurance coverage.

BEHAVIORAL

Referral to financial navigation resources

Patients who self-report needing help with health-related social risks at baseline will be sent a brochure (in preferred language) from patient advocate foundation (PAF), a national non-profit financial navigation organization, where patients can self-refer.

BEHAVIORAL

Patient Reminders

Within 2 weeks prior to primary care appointment, patients will receive a text message or a phone call (if not having a phone that receives text messaging) encouraging patients to discuss the LCS with their provider.

BEHAVIORAL

Provider Reminers

Within 2 weeks prior to primary care appointment, providers will be notified of their patient's eligibility for LCS.

Trial Locations (7)

92627

UCI Health - Costa Mesa, Costa Mesa

92653

UCI Health - Laguna Hills, Laguna Hills

92660

UCI Health - Newport Beach MacArthur, Newport Beach

92670

UCI Health - Tustin, Tustin

92697

UCI Health Gottschalk Medical Plaza, Irvine

92868

UCI Medical Center, Orange

92886

UCI Health-Yorba Linda, Yorba Linda

All Listed Sponsors
lead

University of California, Irvine

OTHER

NCT06000683 - Empowering Patients' Lung Cancer Screening Uptake | Biotech Hunter | Biotech Hunter